Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice

Human Molecular Genetics

Volumn 18, Issue 9, 2009, Pages 1652-1660

  Suzuki, Go ^a   Harper, Kathryn M ^a   Hiramoto, Takeshi ^a   Sawamura, Takehito ^a   Lee, Moonsook ^a   Kang, Gina ^a   Tanigaki, Kenji ^b   Buell, Mahalah ^c   Geyer, Mark A ^c   Trimble, William S ^d   Agatsuma, Soh ^a   Hiroi, Noboru ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Research Institute   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEPTIN; SEPTIN 5; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COGNITION; CONTROLLED STUDY; GENETIC ASSOCIATION; MALE; MAZE TEST; MOTOR ACTIVITY; MOUSE; NONHUMAN; PHENOTYPE; PLEIOTROPY; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SEPTIN 5 DEFICIENCY; SMELLING; SOCIAL INTERACTION; STARTLE REFLEX; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CELL CYCLE PROTEINS; FEMALE; GENE SILENCING; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY;

MUS;

EID: 64549125998     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp086     Document Type: Article

References (57)

1. Goldberg, R., Motzkin, B., Marion, R., Scambler, P.J. and Shprintzen, R.J. (1993) Velo-cardio-facial syndrome: A review of 120 patients. Am. J. Med. Genet., 45, 313-319.
2. Swillen, A., Devriendt, K., Legius, E., Eyskens, B., Dumoulin, M., Gewillig, M. and Fryns, J.P. (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: A study of 37 children and adolescents with VCFS. J. Med. Genet., 34, 453-458.
3. Moss, E.M., Batshaw, M.L., Solot, C.B., Gerdes, M., Donald-McGinn, D.M., Driscoll, D.A., Emanuel, B.S., Zackai, E.H. and Wang, P.P. (1999) Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J. Pediatr., 134, 193-198.
4. Gerdes, M., Solot, C., Wang, P.P., Moss, E., LaRossa, D., Randall, P., Goldmuntz, E., Clark, B.J. III, Driscoll, D.A., Jawad, A. et al. (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am. J. Med. Genet., 85, 127-133.
5. Niklasson, L., Rasmussen, P., Oskarsdottir, S. and Gillberg, C. (2002) Chromosome 22q11 deletion syndrome (CATCH 22): Neuropsychiatric and neuropsychological aspects. Dev. Med. Child Neurol., 44, 44-50.
6. Sobin, C., Kiley-Brabeck, K. and Karayiorgou, M. (2005) Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol. Psychiatry, 10, 553-562.
7. Edelmann, L., Pandita, R.K., Spiteri, E., Funke, B., Goldberg, R., Palanisamy, N., Chaganti, R.S., Magenis, E., Shprintzen, R.J. and Morrow, B.E. (1999) A common molecular basis for rearrangement disorders on chromosome 22q11. Hum. Mol. Genet., 8, 1157-1167.
8. Ensenauer, R.E., Adeyinka, A., Flynn, H.C., Michels, V.V., Lindor, N.M., Dawson, D.B., Thorland, E.C., Lorentz, C.P., Goldstein, J.L., McDonald, M.T. et al. (2003) Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am. J. Human Genet., 73, 1027-1040.
9. Hassed, S.J., Hopcus-Niccum, D., Zhang, L., Li, S. and Mulvihill, J.J. (2004) A new genomic duplication syndrome complementary to the velocardiofacial (22q11 deletion) syndrome. Clin. Genet., 65 400-404.
10. Portnoi, M.F., Lebas, F., Gruchy, N., Ardalan, A., Biran-Mucignat, V., Malan, V., Finkel, L., Roger, G., Ducrocq, S., Gold, F. et al. (2005) 22q11.2 duplication syndrome: Two new familial cases with some overlapping features with DiGeorge/velocardiofacial syndromes. Am. J. Med. Genet. A, 137, 47-51.
11. Sparkes, R., Chernos, J. and Dicke, F. (2005) Duplication of the 22q11.2 region associated with congenital cardiac disease. Cardiol. Young, 15, 229-231.
12. Yobb, T.M., Somerville, M.J., Willatt, L., Firth, H.V., Harrison, K., MacKenzie, J., Gallo, N., Morrow, B.E., Shaffer, L.G., Babcock, M. et al. (2005) Microduplication and triplication of 22q11.2: A highly variable syndrome. Am. J. Hum. Genet., 76, 865-876.
13. de La Rochebrochard, C., Joly-Helas, G., Goldenberg, A., Durand, I., Laquerriere, A., Ickowicz, V., Saugier-Veber, P., Eurin, D., Moirot, H., Diguet, A. et al. (2006) The intrafamilial variability of the 22q11.2 microduplication encompasses a spectrum from minor cognitive deficits to severe congenital anomalies. Am. J. Med. Genet. A, 140, 1608-1613.
14. Alberti, A., Romano, C., Falco, M., Cali, F., Schinocca, P., Galesi, O., Spalletta, A., Di, B.D. and Fichera, M. (2007) 1.5 Mb de novo 22q11.21 microduplication in a patient with cognitive deficits and dysmorphic facial features. Clin. Genet., 71, 177-182.
15. Engels, H., Brockschmidt, A., Hoischen, A., Landwehr, C., Bosse, K., Walldorf, C., Toedt, G., Radlwimmer, B., Propping, P., Lichter, P. and Weber, R.G. (2007) DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation. Neurology, 68, 743-750.
16. Mukaddes, N.M. and Herguner, S. (2007) Autistic disorder and 22q11.2 duplication. World J. Biol. Psychiatry, 8, 127-130.
17. Cai, G., Edelmann, L., Goldsmith, J.E., Cohen, N., Nakamine, A., Reichert, J.G., Hoffman, E.J., Zurawiecki, D.M., Silverman, J.M., Hollander, E. et al. (2008) Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med. Genomics, 1, 50.
18. Ou, Z., Berg, J.S., Yonath, H., Enciso, V.B., Miller, D.T., Picker, J., Lenzi, T., Keegan, C.E., Sutton, V.R., Belmont, J. et al. (2008) Microduplications of 22q11.2 are frequently inherited and are associated with variable phenotypes. Genet. Med., 10, 267-277.
19. Ramelli, G.P., Silacci, C., Ferrarini, A., Cattaneo, C., Visconti, P. and Pescia, G. (2008) Microduplication 22q11.2 in a child with autism spectrum disorder: Clinical and genetic study. Dev. Med. Child Neurol., 50, 953-955.
20. Wentzel, C., Fernstrom, M., Ohrner, Y., Anneren, G. and Thuresson, A.C. (2008) Clinical variability of the 22q11.2 duplication syndrome. Eur. J. Med. Genet., 51, 501-510.
21. Yu, S., Cox, K., Friend, K., Smith, S., Buchheim, R., Bain, S., Liebelt, J., Thompson, E. and Bratkovic, D. (2008) Familial 22q11.2 duplication: a three-generation family with a 3-Mb duplication and a familial 1.5-Mb duplication. Clin. Genet., 73, 160-164.
22. Henry, J.C., van Amelsvoort, T., Morris, R.G., Owen, M.J., Murphy, D.G. and Murphy, K.C. (2002) An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS). Neuropsychologia, 40, 471-478.
23. Bassett, A.S., Hodgkinson, K., Chow, E.W., Correia, S., Scutt, L.E. and Weksberg, R. (1998) 22q11 deletion syndrome in adults with schizophrenia. Am. J. Med. Genet., 81, 328-337.
24. van Amelsvoort, T., Henry, J., Morris, R., Owen, M., Linszen, D., Murphy, K. and Murphy, D. (2004) Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome. Schizophr. Res., 70, 223-232.
25. Chow, E.W., Watson, M., Young, D.A. and Bassett, A.S. (2006) Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr. Res., 87, 270-278.
26. Gothelf, D., Feinstein, C., Thompson, T., Gu, E., Penniman, L., Van, S.E., Kwon, H., Eliez, S. and Reiss, A.L. (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am. J. Psychiatry, 164, 663-669.
27. Debbane, M., Glaser, B., David, M.K., Feinstein, C. and Eliez, S. (2006) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications. Schizophr. Res., 84, 187-193.
28. Antshel, K.M., Aneja, A., Strunge, L., Peebles, J., Fremont, W.P., Stallone, K., AbdulSabur, N., Higgins, A.M., Shprintzen, R.J. and Kates, W.R. (2007) Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion). J. Autism Dev. Disord., 37, 1776-1786.
29. Fine, S.E., Weissman, A., Gerdes, M., Pinto-Martin, J., Zackai, E.H., Donald-McGinn, D.M. and Emanuel, B.S. (2005) Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J. Autism Dev. Disord., 35, 461-470.
30. Kates, W.R., Antshel, K.M., Fremont, W.P., Shprintzen, R.J., Strunge, L.A., Burnette, C.P. and Higgins, A.M. (2007) Comparing phenotypes in patients with idiopathic autism to patients with velocardiofacial syndrome (22q11 DS) with and without autism. Am. J. Med. Genet. A, 143A, 2642-2650.
31. Hiroi, N., Zhu, H., Lee, M., Funke, B., Arai, M., Itokawa, M., Kucherlapati, R., Morrow, B., Sawamura, T. and Agatsuma, S. (2005) A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. Proc. Natl Acad. Sci. USA, 102, 19132-19137.
32. Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., Sparks, C., Choi, C.H., Oghalai, J., Curran, S. et al. (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome. Proc. Natl Acad. Sci. USA, 103, 7729-7734.
33. Long, J.M., Laporte, P., Merscher, S., Funke, B., Saint-Jore, B., Puech, A., Kucherlapati, R., Morrow, B.E., Skoultchi, A.I. and Wynshaw-Boris, A. (2006) Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics, 7 247-257.
34. Caltagarone, J., Rhodes, J., Honer, W.G. and Bowser, R. (1998) Localization of a novel septin protein, hCDCrel-1, in neurons of human brain. Neuroreport, 9, 2907-2912.
35. Kinoshita, A., Noda, M. and Kinoshita, M. (2000) Differential localization of septins in the mouse brain. J. Comp. Neurol., 428, 223-239.
36. Peng, X.R., Jia, Z., Zhang, Y., Ware, J. and Trimble, W.S. (2002) The septin CDCrel-1 is dispensable for normal development and neurotransmitter release. Mol. Cell Biol., 22, 378-387.
37. Beites, C.L., Xie, H., Bowser, R. and Trimble, W.S. (1999) The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat. Neurosci., 2, 434-439.
38. Dong, Z., Ferger, B., Paterna, J.C., Vogel, D., Furler, S., Osinde, M., Feldon, J. and Bueler, H. (2003) Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc. Natl Acad. Sci. USA, 100, 12438-12443.
39. Honer, W.G., Falkai, P., Bayer, T.A., Xie, J., Hu, L., Li, H.Y., Arango, V., Mann, J.J., Dwork, A.J. and Trimble, W.S. (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb. Cortex, 12, 349-356.
40. Barr, A.M., Young, C.E., Sawada, K., Trimble, W.S., Phillips, A.G. and Honer, W.G. (2004) Abnormalities of presynaptic protein CDCrel-1 in striatum of rats reared in social isolation: Relevance to neural connectivity in schizophrenia. Eur. J. Neurosci., 20, 303-307.
41. Zhu, H., Lee, M., Agatsuma, S. and Hiroi, N. (2007) Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice. Hum. Mol. Genet., 16, 820-836.
42. Wolfer, D.P., Crusio, W.E. and Lipp, H.P. (2002) Knockout mice: Simple solutions to the problems of genetic background and flanking genes. Trends Neurosci., 25, 336-340.
43. Flaherty, L. and Bolivar, V. (2007). In Jones, B.C. and Mormede, P. (eds), Neurobehavioral Genetics, Taylor & Francis, New York, pp. 115-127.
44. Geyer, M.A., McIlwain, K.L. and Paylor, R. (2002) Mouse genetic models for prepulse inhibition: An early review. Mol. Psychiatry, 7 1039-1053.
45. Braff, D.L., Geyer, M.A. and Swerdlow, N.R. (2001) Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology, 156, 234-258.
46. Baker, K.D. and Skuse, D.H. (2005) Adolescents and young adults with 22q11 deletion syndrome: Psychopathology in an at-risk group. Br. J. Psychiatry, 186, 115-120.
47. Gogos, J.A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D. and Karayiorgou, M. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl Acad. Sci. USA, 95, 9991-9996.
48. Papaleo, F., Crawley, J.N., Song, J., Lipska, B.K., Pickel, J., Weinberger, D.R. and Chen, J. (2008) Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J. Neurosci., 28, 8709-8723.
49. Henderson, N.D., Turri, M.G., DeFries, J.C. and Flint, J. (2004) QTL analysis of multiple behavioral measures of anxiety in mice. Behav. Genet., 34, 267-293.
50. Bassett, A.S., Caluseriu, O., Weksberg, R., Young, D.A. and Chow, E.W. (2007) Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol. Psychiatry, 61, 1135-1140.
51. Gothelf, D., Eliez, S., Thompson, T., Hinard, C., Penniman, L., Feinstein, C., Kwon, H., Jin, S., Jo, B., Antonarakis, S.E. et al. (2005) COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat. Neurosci., 8, 1500-1502.
52. Gothelf, D., Michaelovsky, E., Frisch, A., Zohar, A.H., Presburger, G., Burg, M., viram-Goldring, A., Frydman, M., Yeshaya, J., Shohat, M. et al. (2007) Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome. Int. J. Neuropsychopharmacol., 10, 301-308.
53. Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., Jurecic, V., Ogunrinu, G., Sutherland, H.F., Scambler, P.J. et al (2001) Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature, 410, 97-101.
54. Nagy, A., Rossant, J., Nagy, R., bramow-Newerly, W. and Roder, J.C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl Acad. Sci. USA, 90, 8424-8428.
55. Simpson, E.M., Linder, C.C., Sargent, E.E., Davisson, M.T., Mobraaten, L.E. and Sharp, J.J. (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet., 16, 19-27.
56. Agatsuma, S., Lee, M., Zhu, H., Chen, K., Shih, J.C., Seif, I. and Hiroi, N. (2006) Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum. Mol. Genet., 15, 2721-2731.
57. Kobayakawa, K., Kobayakawa, R., Matsumoto, H., Oka, Y., Imai, T., Ikawa, M., Okabe, M., Ikeda, T., Itohara, S., Kikusui, T. et al. (2007) Innate versus learned odour processing in the mouse olfactory bulb. Nature, 450, 503-508.